MedTrace Logo

Cost-effectiveness of Reduction Mammaplasty

NCT00992368 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-03-04

No results posted yet for this study

Summary

Several works show breast hypertrophy as pain cause, postural alterations, dermatitis and decrease of the functional capacity and of the self-esteem. The economical evaluations are destined to esteem the costs in alternative ways of attendance to the health, comparing, for instance, clinical strategies with surgical strategies.

OBJECTIVE: To analyze cost-effectiveness in reduction mammaplasty.

Conditions

  • Breast,Hypertrophy
  • Cost-effectiveness

Interventions

PROCEDURE

reduction mammaplasty

patients submitted to reduction mammaplasty

Sponsors & Collaborators

  • Universidade do Vale do Sapucai

    collaborator OTHER

  • Federal University of São Paulo

    lead OTHER

Principal Investigators

  • CARLOS DM ARAUJO, MD, PhD · Federal University of São Paulo

  • DANIELA F VEIGA, MD, PhD · Federal University of São Paulo

  • BERNARDO S HOCHMAN, MD, PhD · Federal University of São Paulo

  • LUIZ EF ABLA, MD, PhD · Federal University of São Paulo

  • LYDIA M FERREIRA, MD, PhD · Federal University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-12-31
Completion
2012-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00992368 on ClinicalTrials.gov